Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Weyer

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|March 14, 2015
Discovery, innovation, and new frontiers in tuberculosis diagnostics: reflections and expectationsKarin Weyer
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 12, 2018
Inclusion of TB diagnostics on the WHO Essential Diagnostics ListChristopher Gilpin, Karin Weyer
Bulletin of the World Health Organization|November 21, 2018
Towards all-oral and shorter treatment regimens for drug-resistant tuberculosisKarin Weyer, Dennis Falzon, Ernesto Jaramillo
The Journal of Infectious Diseases|October 15, 2011
Viewpoint TB diagnostics: what does the world really need?Karin Weyer, Susanne Carai, Paul Nunn
The New England Journal of Medicine|January 18, 2013
Linezolid for extensively drug-resistant tuberculosisErnesto Jaramillo, Karin Weyer, Mario Raviglione
The Lancet. Respiratory Medicine|December 11, 2013
Drug-resistant tuberculosis: latest advancesDennis Falzon, Karin Weyer, Mario C Raviglione
The European Respiratory Journal|April 28, 2017
Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosisDennis Falzon, Ernesto Jaramillo, Christopher Gilpin, et al.
Expert Review of Anti-Infective Therapy|April 3, 2008
Acquired rifamycin resistance: pharmacology and biologyRobert S Wallis, Karin Weyer, P Bernard Fourie
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2018
The Role of Novel Approaches and New Findings in the Pharmacology of Tuberculosis Medicines in Improving Treatment OutcomesDennis Falzon, Ernesto Jaramillo, Christopher Gilpin, et al.
The European Respiratory Journal|December 22, 2012
Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysisAndrea Pantoja, Christopher Fitzpatrick, Anna Vassall, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|March 14, 2015
Discovery, innovation, and new frontiers in tuberculosis diagnostics: reflections and expectationsKarin Weyer
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 12, 2018
Inclusion of TB diagnostics on the WHO Essential Diagnostics ListChristopher Gilpin, Karin Weyer
Bulletin of the World Health Organization|November 21, 2018
Towards all-oral and shorter treatment regimens for drug-resistant tuberculosisKarin Weyer, Dennis Falzon, Ernesto Jaramillo
The Journal of Infectious Diseases|October 15, 2011
Viewpoint TB diagnostics: what does the world really need?Karin Weyer, Susanne Carai, Paul Nunn
The New England Journal of Medicine|January 18, 2013
Linezolid for extensively drug-resistant tuberculosisErnesto Jaramillo, Karin Weyer, Mario Raviglione
The Lancet. Respiratory Medicine|December 11, 2013
Drug-resistant tuberculosis: latest advancesDennis Falzon, Karin Weyer, Mario C Raviglione
The European Respiratory Journal|April 28, 2017
Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosisDennis Falzon, Ernesto Jaramillo, Christopher Gilpin, et al.
Expert Review of Anti-Infective Therapy|April 3, 2008
Acquired rifamycin resistance: pharmacology and biologyRobert S Wallis, Karin Weyer, P Bernard Fourie
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2018
The Role of Novel Approaches and New Findings in the Pharmacology of Tuberculosis Medicines in Improving Treatment OutcomesDennis Falzon, Ernesto Jaramillo, Christopher Gilpin, et al.
The European Respiratory Journal|December 22, 2012
Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysisAndrea Pantoja, Christopher Fitzpatrick, Anna Vassall, et al.
Pageof 5